Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MROH7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | APP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | APOD | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | NEXN | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | RTN4IP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | GJB5 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
mRNA | ADGRE5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | GREM1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | MTMR9 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | ITGB4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |